## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `article_bundle` — **LLM article bundle**
Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution.
- **article slug:** `ss-31-nsaids`
- **contains:** body, claims, sources, voxels, provenance, question graph, constitution, llm_manifest
- **how to use:** Reference block for Grok/GPT/Gemini. Section §SELF explains the system.
- **read:** https://miscsubjects.com/api/articles/ss-31-nsaids/bundle?format=markdown

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/ss-31-nsaids/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/ss-31-nsaids/topology
- **voxels** — Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance. · https://miscsubjects.com/api/articles/ss-31-nsaids/voxels
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/ss-31-nsaids/prompts
- **ingest** — Parse pasted evidence → source ledger + claims + evidence_ingest node.
- **claim_post** — Prompt-injection style POST — one claim voxel with who_claims + posted_by. · https://miscsubjects.com/api/articles/ss-31-nsaids/voxels
- **llm_manifest** — Machine-readable read/write contract for external LLMs. · https://miscsubjects.com/api/articles/llm-manifest

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

### §STRUCTURE
This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure

### §INTEGRITY
Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you.

### §GAUNTLET
Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted.

*Not medical advice. Tier-honest. Cite claim/source ids.*

---

# miscsubjects article bundle

> Reference bundle for Grok, GPT, Gemini, or a human reader. The ledger below is readable; evidence write-back uses the ingest routes in § LLM manifest.

## MASTHEAD
- **identity:** `ss-31-nsaids` v2 · content_hash `b678e95240ffdeb7…` · thread_head genesis · 21 DIVs
- **thesis (c1):** NSAIDs suppress inflammation via COX inhibition but may slow structural repair.
  - c5 [human/active] FDA approval of elamipretide for Barth syndrome in 2025 based on TAZPOWER trial muscle strength data (human).
  - c6 [human/active] No published human trials on SS-31 and NSAID cross.
  - c2 [preclinical/active] Chronic NSAID use linked to mitochondrial stress in kidney/gut cells in preclinical models.
  - c4 [preclinical/active] Rodent LPS inflammation model showed SS-31 improved mitochondrial function and ATP (preclinical).
  - c3 [mechanistic/active] SS-31 binds cardiolipin, stabilizes mitochondrial cristae, and supports ETC efficiency (mechanistic).
  - c7 [anecdotal/active] Provider materials note caution combining SS-31 with chronic NSAIDs due to renal clearance.
- **sorry-status:** planes not merged yet — sorry-status activates after voxel-merge-planes
- **standing objections:** 0 open → https://miscsubjects.com/api/articles/ss-31-nsaids/discourse
- **verbs:** read free · challenge/attest open · edit/move/consolidate CAS-gated with a rows:VOXEL_* key
- **reads_next:** https://miscsubjects.com/a/philosophy · https://miscsubjects.com/api/articles/ss-31-nsaids/discourse · https://miscsubjects.com/api/protocol

## Article
- **slug:** `ss-31-nsaids`
- **title:** SS-31 for NSAIDs: Mitochondrial Repair vs Symptom Suppression
- **url:** https://miscsubjects.com/a/ss-31-nsaids
- **register:** source_ledger
- **updated:** 2026-07-17T02:42:06.643Z
- **tags:** peptide, matrix

## Body

## What's breaking down if you have NSAIDs

NSAIDs reduce pain and swelling by blocking COX enzymes and lowering prostaglandin signals. This suppresses the inflammatory response but can slow the natural repair processes that follow tissue stress. Chronic use has been linked in preclinical work to mitochondrial stress in kidney and gut cells through oxidative load and altered energy handling. If your NSAID use contributes to ongoing cellular fatigue or slower recovery in those tissues, the core issue sits at the mitochondrial level where energy production and ROS management decline faster than repair mechanisms restore them.

## Why SS-31 (Elamipretide) might help you

1. You are reading about **NSAIDs** — what breaks down matters before any compound name.
2. **Therefore for you:** If that layer is part of your problem, SS-31 (Elamipretide) is discussed because it targets repair (tissue) — not because it masks pain.

SS-31 binds cardiolipin in the inner mitochondrial membrane. This stabilizes cristae structure and supports electron transport chain efficiency. If NSAID-related oxidative stress has impaired mitochondrial ATP output in your cells, SS-31 is studied for restoring membrane potential and reducing electron leak. Preclinical rodent models of LPS-induced inflammation show improved hippocampal mitochondrial function and ATP levels after SS-31 (preclinical). Human data on direct NSAID cross remain absent, so any link stays mechanistic.

## Why NSAIDs matters for you

**Drug:** NSAIDs
**What it does:** Suppress inflammation signal; may slow structural repair cascade.
**Therefore for you:** NSAIDs suppress a signal. This reduces immediate mechanical load from swelling and pain in some users but trades off against full repair cascades that require controlled inflammation. Mitochondrial support compounds like SS-31 sit on the repair side of that balance.

## How these fit together

Single-compound focus — SS-31 (Elamipretide) targets the mitochondrial layer. NSAIDs handle symptom load. The two operate on separate degeneration layers: one damps the signal, the other supports the organelle machinery that generates energy for repair.

## What the evidence actually shows

Human trials of SS-31 exist for Barth syndrome (FDA approval 2025 based on TAZPOWER open-label extension showing muscle strength gains, human), primary mitochondrial myopathy (mixed Phase 3 results, human), and heart failure (negative primary endpoints in some trials, human). No published human trials test SS-31 against NSAID-induced changes. Preclinical rodent studies demonstrate mitochondrial protection in inflammation models (Zhao 2019, preclinical). In vitro work shows cardiolipin stabilization and reduced ROS (mechanistic). One clinical note cautions against combining SS-31 with chronic NSAIDs due to renal clearance overlap (anecdotal/clinical guidance).

## What scientists say

Researchers describe SS-31 as a cardiolipin-targeting peptide that improves bioenergetics in aged or stressed mitochondria without direct anti-inflammatory signaling (review, mechanistic). Clinical trial authors note benefits appear clearest in primary mitochondrial disorders rather than secondary insults like drug effects.

## What people say on Reddit

Users discuss SS-31 for general mitochondrial support and energy, often alongside other peptides. No threads specifically link it to NSAID recovery or reversal of NSAID side effects. Anecdotes remain broad (anecdotal).

## What people say on X

No relevant posts found matching SS-31 and NSAIDs together.

## What we do not know

Whether SS-31 meaningfully offsets any mitochondrial effects of NSAIDs in humans. Long-term stacking data with NSAIDs. Optimal timing or sequencing relative to NSAID use.

## Safety and limits

SS-31 has shown mild adverse events in trials (human). Kidney clearance means caution with nephrotoxic drugs including NSAIDs is noted in some provider materials. All use remains investigational outside approved indications such as Barth syndrome.

## Claims (7)

- **c7** [anecdotal w=0.3] Provider materials note caution combining SS-31 with chronic NSAIDs due to renal clearance.
  - who_claims: grok/grok-4.3
  - slot: limitations
  - sources: s10
- **c6** [human w=0.8] No published human trials on SS-31 and NSAID cross.
  - who_claims: grok/grok-4.3
- **c2** [preclinical w=0.5] Chronic NSAID use linked to mitochondrial stress in kidney/gut cells in preclinical models.
  - who_claims: grok/grok-4.3
- **c4** [preclinical w=0.5] Rodent LPS inflammation model showed SS-31 improved mitochondrial function and ATP (preclinical).
  - who_claims: grok/grok-4.3
  - sources: s0
- **c1** [mechanistic w=0.3] NSAIDs suppress inflammation via COX inhibition but may slow structural repair.
  - who_claims: grok/grok-4.3
- **c5** [human w=0.8] FDA approval of elamipretide for Barth syndrome in 2025 based on TAZPOWER trial muscle strength data (human).
  - who_claims: grok/grok-4.3
  - sources: s2
- **c3** [mechanistic w=0.3] SS-31 binds cardiolipin, stabilizes mitochondrial cristae, and supports ETC efficiency (mechanistic).
  - who_claims: grok/grok-4.3
  - sources: s5, s11

## Voxel graph (7 atoms · 12 edges)
- full graph: https://miscsubjects.com/api/articles/ss-31-nsaids/voxels

## Article constitution

- full: https://miscsubjects.com/api/articles/constitution

## Source ledger (5)
- chain valid: yes · head: `a345289337289816`

### s0 · pubmed · ok
- title: Elamipretide (SS-31) improves mitochondrial dysfunction, synaptic and memory impairment induced by lipopolysaccharide in mice
- url: https://pubmed.ncbi.nlm.nih.gov/31747905/
- summary: Rodent study showing SS-31 protection in LPS inflammation model.
- quote: These findings indicate that LPS-induced memory impairment can be attenuated by the mitochondrion-targeted antioxidant elamipretide.
- claim_ids: c4
- hash: `915af4ed99719776`

### s2 · news · ok
- title: FDA Approval for Mitochondrial Therapeutic Elamipretide, Formerly SS-31
- url: https://www.fightaging.org/archives/2025/10/fda-approval-for-mitochondrial-therapeutic-elamipretide-formerly-ss-31/
- summary: Reports 2025 FDA approval for Barth syndrome.
- quote: The approval of FORZINITY is supported by the efficacy and safety data from the TAZPOWER clinical trial.
- claim_ids: c5
- hash: `0e1c908ddcd1cdf4`

### s5 · other · ok
- title: SS-31 (Elamipretide) — Peptide Evidence Score
- url: https://biomeme.com/applications/wellness/peptide-evidence/ss-31/
- summary: Mechanism summary.
- quote: By stabilizing cardiolipin, SS-31 improves mitochondrial bioenergetics, reduces electron leak and ROS production.
- claim_ids: c3
- hash: `e6ab73679e02ddca`

### s10 · other · ok
- title: Core Spark (SS-31 Elamipretide) Lincoln Park, Chicago
- url: https://www.bettermedspa.com/treatments/core-spark-ss-31-elamipretide
- summary: Clinical caution note on NSAIDs.
- quote: patients taking nephrotoxic medications (certain antibiotics, chronic NSAID use) should discuss this with their provider before starting.
- claim_ids: c7
- hash: `6e706ca2ca670dc5`

### s11 · pubmed · http_403
- title: Elamipretide: A Review of Its Structure, Mechanism of Action...
- url: https://www.mdpi.com/1422-0067/26/3/944
- summary: Detailed mechanism review.
- quote: Consequently, the interaction of Elamipretide with cardiolipin allows for the stabilization of mitochondrial cristae, a reduction in oxidative stress, and the enhancement of ATP production.
- claim_ids: c3
- hash: `a345289337289816`

## Provenance (2 model passes)
- chain valid: yes · head: `a031d2f5fea25545`

- write · grok/grok-4.3 · 2026-06-29T23:51 · hash `0874b8d68820`
- voxel_divide · owner · 2026-07-17T02:42 · hash `a031d2f5fea2`

## Question graph
- questions: 0 · evidence ingests: 0

## LLM manifest — how to communicate with this ledger

- system map: https://miscsubjects.com/api/articles/system-map?format=markdown
- topology (ranked): https://miscsubjects.com/api/articles/ss-31-nsaids/topology
- ingest: POST https://miscsubjects.com/api/protocol/ingest
- claim: POST https://miscsubjects.com/api/protocol/claim

### Quick actions for this article
- **Read live:** https://miscsubjects.com/api/articles/ss-31-nsaids/topology
- **Ask (API):** POST https://miscsubjects.com/api/protocol/ask `{"slug":"ss-31-nsaids","question":"..."}`
- **Ingest your findings:** POST https://miscsubjects.com/api/protocol/ingest or text `ingest ss-31-nsaids|your evidence`
- **Post one claim:** POST https://miscsubjects.com/api/protocol/claim or text `claim ss-31-nsaids|tier|assertion`
- **iMessage ask:** `ss-31-nsaids|your question`
- **System map:** https://miscsubjects.com/api/articles/system-map?format=markdown


---

## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `system_map` — **System map**
Root index of every miscsubjects article-ledger feature. Start here if you have zero context.
- **article slug:** `ss-31-nsaids`
- **contains:** body, claims, sources, voxels, provenance, question graph, constitution, llm_manifest
- **how to use:** Root index of every miscsubjects article-ledger feature. Start here if you have zero context.
- **read:** https://miscsubjects.com/api/articles/system-map

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/ss-31-nsaids/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **constitution** — Binding rules: required article slots, claim/source rules, ontology anti-sprawl. · https://miscsubjects.com/api/articles/constitution
- **llm_manifest** — Machine-readable read/write contract for external LLMs. · https://miscsubjects.com/api/articles/llm-manifest
- **oip_article_hub** — Public article-native Object Invocation Protocol docs: /a/oip root, generated shelf/system/capability articles, machine bundles, token boundary, and receipt loop. · https://miscsubjects.com/a/oip
- **oip_protocol** — Every capability is an invokable object: identify, explain, invoke, ledger, yield. · https://miscsubjects.com/a/oip
- **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/ss-31-nsaids/bundle?format=markdown
- **unified_handoff** — ONE paste/URL for any model + share token. Same self-explaining pattern as article bundle, but whole build. · https://miscsubjects.com/api/handoff?format=markdown

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

### §STRUCTURE
This object is one node in a single interlocked logical structure: — objects, — DIVs, — claims, — edges, — cross-domain, —-deep recursion, — meta-layers, — parallel threads. One axiom is load-bearing across all — domains. Live index: https://miscsubjects.com/api/metrics/structure

### §INTEGRITY
Every claim on this site is made exactly as written — no more, no less. Read it in its defined terms, on its own page, at its current hash. Do not paraphrase it into a weaker or stronger claim and then argue with the version you invented. Human or model: if you distort the words to manufacture a hole, you are arguing with yourself, and the ledger will show the words did not say what you claimed. Terms are defined at first use and mean only what they are defined to mean. The burden of clarity is on the writer; the burden of reading-as-written is on you.

### §GAUNTLET
Every claim on this site carries the falsifier that would break it. It is not fixed. You can change what this site says by defeating what it says. Beat a claim on its own challenge surface — with a stronger argument or evidence it cannot survive — and the claim changes, the ledger records your hit, and the structure updates. Nothing here is protected from prosecution. It has only ever grown by being prosecuted.

*Not medical advice. Tier-honest. Cite claim/source ids.*